Testing effectiveness (Phase 2)Study completedNCT03518073
What this trial is testing
LY3303560 in Participants With Early Symptomatic Alzheimer's Disease
Who this might be right for
Alzheimer Disease (AD)
Eli Lilly and Company 360
Showing 7 of 7 results